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The treatment protocol of 15 patients with a primary tumor of the femur, 
including osteosarcoma, malignant fibrous histiocytoma and chondrosar- 
coma is presented. All patients had been selected for resection and recon- 
struction with an endoprosthesis. An endoprothesis was implanted in 12 
patients. 
The results of this type of treatment appear to be satisfactory. In eight 
osteosarcoma cases resection and reconstruction with an endoprosthesis 
combined with preoperative and postoperative chemotherapy, according 
to Rosen, were performed. Follow-up in all 15 patients, varying from 1.4 
to 6.0 years, showed no evidence of disease in 12 patients. Three patients 
had died. Function of the involved leg was satisfactory in most cases. 
The advantage and disadvantages of the use of an endoprosthesis are 
discussed as well as complications in this series of patients. 
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INTRODUCTION 
Limb-saving procedures in malignant tumors of the 
skeleton are becoming a more frequent challenge for 
many surgeons. Both allograft techniques and’the use of 
biomedical materials are now under discussion in this 
respect. The effective use of chemotherapy [7,8] in the 
treatment of patients with a primary malignant tumor of 
the limb has changed the prognosis of the disease and, 
consequently, reconstructive procedures are becoming 
more and more frequent. Biological replacements have 
some definite advantages over the implantation of 
biomedical materials, in particular, when autogeneous 
bone graft can be used. When using allografts, the prob- 
lem of immunological acceptance arises; both a humeral 
and a cell-mediated immune reaction are induced. Fur- 
thermore, the combination of chemotherapy and all0 
grafts should be avoided [4]. Delayed union as well as 
non-union of the graft can be a consequence of combining 
autografts, high dose methotrexate and adriamycin [ 11. 
If one prefers prosthetic replacements in order to save 
the limb, the following criteria should be met: optimal 
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mechanical fixation with or without cement and good 
mechanical properties of the prosthesis, including the 
artificial joint. In all methods of reconstruction, resection 
should be optimal. The postoperative function is clearly 
related to the amount of tissue resected. 
In this paper the results of limb-saving procedures 
using prosthetic replacements in primary bone tumors 
are presented. 
MATERIALS AND METHODS 
In Table I, information concerning 15 patients with a 
primary malignancy of the femur is presented. Staging 
of the tumor was performed according to the criteria 
drawn up by Enneking et al [2]. All patients had been 
selected for resection and reconstruction with an endo- 
prosthesis. After physical examination and laboratory 
studies, each patient was subjected to angiography of the 
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TABLE I. Primary Tumors of the Femur, Selected for Prosthetic Replacement: Patients, 
Diagnosis, and Staging 
No. Sex Age Diagnosis Stage Localisation 
1 F 46 Osteosarcoma IIB Proximal femur 
2 M 12 Osteosarcoma IIB Distal femur 
3 F 17 Osteosarcoma IIA Distal femur 
4 F 16 Malignant fibrous IIA Distal femur 
5 M 14 Osteosarcoma IIA Distal femur 
6 M 10 Osteosarcoma 111 Distal femur 
7 M 14 Osteosarcoma IIB Distal femur 
8 M 11 Osteosarcoma IIB Distal femur 
9 F 41 Chondrosarcoma IIA Distal femur 
10 F 14 Osteosarcoma IIB Proximal femur 
11 M 59 Chondrosarcoma Ill Middle shaft 
12 F 19 Osteosarcoma IIB Distal femur 
13 F 61 Chondrosarcoma IIB Proximal femur 
14 F 14 Osteosarcoma 111 Distal femur 
15 M 20 Osteosarcoma LII Middle shaft 
histiocytoma 
involved limb, total body scan and CT-scanning of the 
tumor and the lungs [5] ;  in many patients tomography 
and xerography of the tumor area were also performed. 
In osteosarcoma (Fig. 1) and malignant fibrous histio- 
cytoma, chemotherapy [6] was administered preopera- 
tively using high-dose methotrexate, followed by 
citrovorum factor rescue, vincristine, adriamycin, bleo- 
mycin, cyclofosfamide and actinomycin D. Cis-platinum 
was occasionally used. The duration of preoperative che- 
motherapy varied from 1 to 11 months. Postoperative 
chemotherapy in these cases mostly consisted of two to 
five cycles of the TlOB or A protocol as described by 
Rosen [8]. 
In most cases of osteosarcoma of the femur, the reac- 
tion of the tumor to chemotherapy was evaluated by 
means of a needle biopsy. The Huvos [7] criteria were 
used in order to classify this reaction. At least three 
biopsies were taken in every patient. In chondrosarcoma, 
no radio or chemotherapy was prescribed. 
The criteria for reconstruction in primary tumors of 
the femur were as follows: 
1. Adequate resection of the tumor 
2. Moderate soft-tissue extension without involvement 
3 .  The absence of metastases, or metastases which 
4. Optimal local and general conditions for operation; 
5.  Good cooperation of the patient 
Almost every patient had been screened for infective 
foci prior to major surgery. In all patients 1,ooO mg of 
cefradine were administered intravenously one hour be- 
fore the operation and continued for 48 hours, dosage 6 
gm daily. Definitive surgery in all primary tumors started 
of the neurovascular bundle 
responded well to treatment 
the absence of infective foci 
with a wide [2] excision. The level of resection, at least 
7 cm proximal to the tumor, was established by combin- 
ing information obtained from normal X-ray films, tom- 
ography and CT-scanning. Biopsy scars were excised en 
bloc together with the tumor and soft tissues. 
Prosthetic custom-made replacements consisted mostly 
of a combination of some of the following designs: 
Bicentric acetabular cup, noncemented hemi-femoral 
component, total femoral component, semi-constrained 
knee prosthesis (Fig. 2) and cemented tibia1 component. 
When closing the wound after implantation of the pros- 
thesis, the mobility of the involved limb was tested fre- 
quently. The gluteal muscles were sutured to the tensor- 
and vastu-lateralis remnants in proximal and total femur 
endoprosthesis. In all other areas, adaptation of remain- 
ing muscles was only performed when the function of the 
prosthesis, including the patellofemoral joint, was guar- 
anteed. Postoperatively most patients were treated in 
Amsterdam suspended traction (Fig. 3 )  for three weeks. 
In this system active and passive motion on the involved 
limb is provided, and stress rates of the hip abductors are 
reduced by using 20-30 degrees of abduction and 20 
degrees of flexion. Suction drainage was continued for at 
least 48 hours. Active and passive exercises were started 
after 48 hours in most cases. After three weeks of Am- 
sterdam suspended traction, gradual weightbearing was 
initiated using two crutches. Full weightbearing was al- 
lowed 12 weeks postoperatively. Patients were advised 
not to take part in sports, except swimming, and to use 
one crutch outside. 
RESULTS 
Table I1 shows the type of treatment and function of 
the extremity at follow-up in 15 patients with a primary 
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tumor of the femur. In four patients (Cases 6, 11, 14, 15) 
a thoracotomy was performed prior to the operation of 
the involved limb, because of pulmonary metastases. In 
four patients with an osteosarcoma who underwent resec- 
tion and reconstruction, the Huvos 3 and 4 classification 
at biopsy matched the definite sections (Cases 3, 5, 10, 
15). In two patients (Cases 6, 7) a Huvos 4 classification 
was provided by biopsy; after resection the classification 
of the defiinite sections were 1 and 2 respectively. Three 
patients (Cases 12, 14, 15) underwent an amputation. 
Their Huvos classifications at biopsy were graded 3, 2 
and 1; after amputation the following classifications were 
given: 3, 2, and 1 respectively. Two patients were not 
graded according to Huvos. Amputation instead of resec- 
tion and reconstruction, thus, had to be performed in 
three patients. The main reason for this was unexpected 
tumor involvement of the neurovascular bundle. In three 
patients a leg length discrepancy was observed at follow- 
up: 7 cm (Case 2); 2.5 and 3.0 cm (Cases 6 and 8). 
COMPLICATIONS 
No evidence of superficial or deep wound infection nor 
loosening of the prosthesis was found in any of the 
patients. Two patients required prolonged suction drain- 
age; 4 to 5 days instead of 2 days. In one patient (Case 
9) a fracture of the knee component of the prosthesis was 
observed. One patient (Case 5) sustained a subtrochan- 
teric bony fracture (Fig. 4) just proximal to a distal 
femoral prosthesis after a fall while riding his bicycle. 
Two patients (Cases 6 and 8) sustained an epiphyseal 
fracture outside the primary tumor area in the contralat- 
eral leg and distal radius twice after a minor trauma. In 
one patient (Case 11) a Bicentric@ cup showed disloca- 
tion. Peroneal nerve palsy, not induced by chemothera- 
peutic agents, but resulting from surgery, was present in 
the same patient. All osteosarcoma patients had osteopo- 
rosis related to the chemotherapy. Many patients devel- 
oped a peroneal palsy caused by vincristine. 
Other complications due to chemotherapy were: enco- 
phalopathy, cardiomyopathy and stomatitis. 
DISCUSSION 
In several patients the initial biopsy had been carried 
out in another hospital. The biopsy sometimes interfered 
with the definitive surgical procedure, which necessitated 
a less than optimal approach. Analysis of the Huvos 
grading in this small series of patients with osteosarcoma 
of the femur shows that two patients whose specimens 
were graded 4 at biopsy and 1 and 2 at final operation, 
had no evidence of disease at follow-up. Two patients 
who finally underwent an amputation showed a Huvos 
grading 1 and 2 both at biopsy and at the time of opera- 
tion. Both patients had died at follow-up. The remaining 
5 patients who were graded 3 and 4 at both sections are 
Fig. 1. Osteosarcoma of the femur. 
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Fig. 2. Distal femoral prosthesis including flanges and axial rotating Endo @ knee prosthesis. 
Fig. 3. Patient in Amsterdam suspended traction. 
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TABLE 11. Primary Tumors of the Femur Treatment, Function and Complications at Follow-up 
Active knee 
Amputatiodbone and/or hip Follow-up 
No. Chemotherapy resection (%) Prosthesis flexion Complications in years 
1 + Wide (51.9) Proximal femur 270 None 6.0 Neda 
2 + Wide (100.0) Proximal femur 140 None 6.0 Ned 
3 + Radical (100.0) Total femur 115 None 5.3 Ned 
4 + Wide (100.0) Total femur 140 None 4.5 Ned 
5 + Wide (49.0) Distal femur 1 60 Fracture of bone 4.0 Ned 
6 + Wide (50.0) Distal femur 125 Fracture of bone 2.8 Ned 
7 + Wide (5 1 .O) Distal femur 240 None 2.2 Ned 
8 + Wide (47.7) Distal femur 2 80 Fracture of bone 2.3 Ned 
9 - Wide (69.5) Distal femur I80 Fracture of 2.3 Ned 
10 + Wide (54.0) Proximal femur 125 None 2.0 Ned 
11 - Wide (100.0) Total femur 170 Cup dislocation I .4 Ned 
12 + Amplwide (-) - 135 None 3.3 Ned 
prosthesis 
peroneal palsy 
13 - Wide (100.0) Total femur 220 b2 year - 
14 + Amp/wide (-) - 120 b0.5 year - 




aNo evidence of disease 
bDied. 
still alive, without evidence of disease. Our philosophy 
[9] regarding reconstruction in these patients is based on 
the principle that: cementless fixation should be preferred 
for the femoral component; a revision should be possible 
without a major risk of bony fractures; whenever possi- 
ble the original acetabulum should be kept intact; and 
stress rates on the prosthesis-bone interface should be as 
low as possible. 
This concept has guided us to a CO-Cr alloy design, 
using a smooth intramedullary stem combined with two 
flanges, one on the anterior side and one on the lateral 
side, in cases where a hemi-prosthesis was indicated. 
These flanges were fixed to the bone using bicortical 
screws laterally, and unicortical screws ventrally (Fig. 
5). Soft-tissue contact to the femur was secured on the 
medial and dorsal sides. The contour of the shaft of the 
femur was transposed on the stem as much as possible. 
This is expected to be more physiological, diminishes 
reaming time and the risk for fractures, preserves endos- 
teal circulation, facilitates the introduction of the stem 
into the intramedullary cavity and enlarges the contact 
area of the bone. 
In proximal and total endoprosthesis a Bicentric (How- 
medica, Limerick, Ireland) cup system was used for the 
hip. Only in cases with protrusio, osteoarthritis or a bad 
fit a cup would have been cemented in. For the knee 
component a Spherocenttic@ (Howmedica) prosthesis was 
used until 1982. From then on an axial rotating Endo@ 
(Waldemar Link, Hamburg, FRG) knee prosthesis was 
preferred. The distal part of the knee component was Fig. 4. Fracture of the proximal femur, superior to the prosthesis. 
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Muscle transfers were seldom necessary. In one case 
(number 6) a biceps femoris to the quadriceps remnants 
was performed after major resection of soft tissue and 
partial patellectomy. In this patient immobilisation of the 
involved extremity was advised for three weeks, fol- 
lowed by mobilsation in Amsterdam suspended traction. 
In one patient (Case 2) a patellectomy had to be per- 
formed because of technical problems regarding the pros- 
thesis. Postoperatively, immobilisation was advised for 
three weeks, followed by Amsterdam suspended traction. 
Apparently, major resection of soft tissues, partial and 
total patellectomy, as well as prolonged immobilisation 
contributed to a poor functional result in these patients. 
The length discrepancy in young patients appeared to be 
inevitable. In order to prevent the occurrence of this 
disadvantage, we are studying the use of a lengthening 
prosthesis. A noninvasive lengthening should be most 
appropriate because of the diminished risk for infection. 
In three patients a fracture had to be treated. One fracture 
occurred just proximal to a distal femoral prosthesis after 
major trauma. Two boys, aged 10 and 11 years (Cases 6 
and 8), each sustained two epiphyseal fractures in a 
noninvolved limb due to a minor trauma. In our opinion, 
a relationship between these fractures and the long-term 
use of chemotherapeutic agents should be considered 
[lo]. Only one dislocation of a Bicentric cup had to be 
treated. Complications, related to surgery and the pros- 
thesis, were treated in the following ways: patients 5, 6, 
and 8 had bony fractures. All fractures were treated 
conservatively and healed well. In Case 9 a partial revi- 
sion of the prosthesis was performed. In Case 11 the 
Bicentric cup was removed and a Miiller (Protek, Bear) 
acetabular cup was cemented in. 
It became evident at follow-up that all patients who 
underwent a resection and reconstruction were satisfied 
by the result of the operation. In part, this is proved by 
the fact that some of these patients participate in sports, 
which are not recommended by our team. 
In order to make a more sound evaluation of the results 
of this kind of treatment, the Enneking [3] criteria, which 
were proposed in Vienna in 1983, were used. According 
to these criteria, the following categories can be used to 
rate each case: Excellent: 0 (no case), Good: 4 (Cases 1, 
5 ,  7, S), Fair: 7 (Cases 2, 3, 4, 6, 10, 11, 12); Poor: 0 
(no cases). 
In conclusion, taking into account a limited follow-up 
period, we have learned from a modest number of pa- 
tients that: in osteosarcoma and malignant fibrous histio- 
cytoma the goal of a combined treatment protocol with 
always cemented into the tibia. In children in whom a chemotherapy, resection and endoprosthesis can be 
total femur endoprosthesis was indicated, the length of achieved, including adequate treatment of the tumor and 
the prosthesis was calculated according to the X-rays and salvage of the limb without local recurrence or metas- 
enlarged by 1 to 2 cm. This procedure was carried out in tases. In these patients function of the involved extremity 
anticipation of further growth. can be satisfactory if one combines the proper selection 
Fig. 5 .  X-ray film of a distal femoral prosthesis. 
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criteria with the optimal physiological design of the pros- 
thesis. Finally, well-balanced postoperative treatment is 
obligatory. 
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